Holen Sie sich die Stockscreener-App
115.44
0.23%
0.27
Vorhandelsmarkt:
115.25
-0.19
-0.16%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$115.17
Offen:
$114.86
24-Stunden-Volumen:
9.97M
Relative Volume:
1.02
Marktkapitalisierung:
$285.12B
Einnahmen:
$65.51B
Nettoeinkommen (Verlust:
$8.93B
KGV:
32.49
EPS:
3.5532
Netto-Cashflow:
$14.12B
1W Leistung:
-3.06%
1M Leistung:
+3.65%
6M Leistung:
+16.39%
1J Leistung:
+47.47%
1-Tages-Spanne:
$114.02
$115.99
1-Wochen-Bereich:
$113.57
$122.71
52-Wochen-Spanne:
$76.66
$125.14
Merck Co Inc Stock (MRK) Company Profile
Firmenname
Merck Co Inc
Sektor
Telefon
908-740-4000
Adresse
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, NVS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
115.44 | 283.78B | 65.51B | 8.93B | 14.12B | 3.5532 |
LLY
Lilly Eli Co
|
1,112.00 | 1.01T | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
234.20 | 567.28B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
221.23 | 391.50B | 62.82B | 3.60B | 19.98B | 2.0274 |
NVS
Novartis Ag Adr
|
150.88 | 289.19B | 54.66B | 13.58B | 16.05B | 7.0171 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-02-20 | Eingeleitet | Barclays | Overweight |
| 2026-02-13 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-01-08 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-10-13 | Fortgesetzt | Citigroup | Neutral |
| 2025-09-17 | Herabstufung | Berenberg | Buy → Hold |
| 2025-05-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-08 | Herabstufung | Truist | Buy → Hold |
| 2024-12-20 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-04 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-11 | Herabstufung | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-03-11 | Herabstufung | Societe Generale | Hold → Sell |
| 2024-01-04 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-27 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Hold |
| 2023-04-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-03-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Eingeleitet | Jefferies | Buy |
| 2023-02-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-10-10 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-09-14 | Hochstufung | Berenberg | Hold → Buy |
| 2022-07-06 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Fortgesetzt | SVB Leerink | Outperform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Eingeleitet | Goldman | Buy |
| 2021-12-16 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-12-13 | Herabstufung | UBS | Buy → Neutral |
| 2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
| 2021-12-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-11-29 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-11-01 | Hochstufung | Argus | Hold → Buy |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-05-20 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Fortgesetzt | Bernstein | Outperform |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-08-03 | Hochstufung | Goldman | Neutral → Buy |
| 2020-06-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-16 | Eingeleitet | SVB Leerink | Outperform |
| 2019-07-03 | Eingeleitet | Mizuho | Buy |
| 2019-05-28 | Eingeleitet | Goldman | Neutral |
| 2019-05-13 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Bestätigt | Citigroup | Buy |
| 2018-10-09 | Fortgesetzt | Guggenheim | Buy |
| 2018-04-23 | Hochstufung | Goldman | Neutral → Buy |
| 2018-04-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-02-07 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Hochstufung | SunTrust | Hold → Buy |
Alle ansehen
Merck Co Inc Aktie (MRK) Neueste Nachrichten
A Look at Merck & Co Inc (MRK) After 3.5% Decline -- GF Value $118.36 vs Price $114.90 - GuruFocus
Merck & Co. Inc. stock underperforms Monday when compared to competitors - MarketWatch
Merck & Co Inc Stock (MRK) Moved Down by 3.13% on Jun 15: What Signal Does It Send? - TradingKey
Panagora Asset Management Inc. Purchases 567,249 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Resources Management Corp CT ADV - MarketBeat
Vanguard Personalized Indexing Management LLC Grows Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Perryman Financial Advisory Inc. AD Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Mariner LLC Has $289.84 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Kennedy Capital Management LLC Sells 16,448 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Evelyn Partners Investment Management LLP - MarketBeat
Merck & Co. Inc. Stock (US58933Y1055): Valuation and fundamentals in focus after steady trading - AD HOC NEWS
Gross margin % of Merck & Co., Inc. Shs Cert Deposito Arg Repr 1/5 Sh – BCBA:MRK.CI - TradingView
Focus Partners Wealth Has $149.61 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Total common shares outstanding of Merck & Co., Inc. Shs Cert Deposito Arg Repr 1/5 Sh – BCBA:MRK.CI - TradingView
Enterprise value to EBITDA ratio of Merck & Co., Inc. Shs Cert Deposito Arg Repr 1/5 Sh – BCBA:MRK.CI - TradingView
Current ratio of Merck & Co., Inc. Shs Cert Deposito Arg Repr 1/5 Sh – BCBA:MRK.CI - TradingView
Huber Capital Management LLC Buys 10,000 Shares of Merck & Co., Inc. $MRK - MarketBeat
LM Advisors LLC Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
Epoch Investment Partners Inc. Grows Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Arax Advisory Partners Has $30.94 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Brown Advisory Inc. Purchases 36,941 Shares of Merck & Co., Inc. $MRK - MarketBeat
Bollard Group LLC Has $13.90 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
JPMorgan Growth Advantage Fund's Merck & Co Inc(MRK) Holding History - GuruFocus
Merck & Co. Inc. Stock (US58933Y1055): Insider and institutional ownership in focus - AD HOC NEWS
Penn Series Large Core Value Fund's Merck & Co Inc(MRK) Holding History - GuruFocus
Van Lanschot Kempen Investment Management N.V. Sells 82,120 Shares of Merck & Co., Inc. $MRK - MarketBeat
Storgate LLC Acquires Shares of 9,673 Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Korea Investment CORP - MarketBeat
Martingale Asset Management L P Has $34.08 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Platinum Investment Management Ltd. Sells 875,470 Shares of Merck & Co., Inc. $MRK - MarketBeat
Trillium Asset Management LLC Has $10.25 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Macquarie Group Ltd. Has $186.10 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
First National Bank of Omaha Purchases 85,885 Shares of Merck & Co., Inc. $MRK - MarketBeat
Summit Financial LLC Purchases 17,528 Shares of Merck & Co., Inc. $MRK - MarketBeat
9,619,320 Shares in Merck & Co., Inc. $MRK Bought by Cardano Risk Management B.V. - MarketBeat
Merck & Co., Inc. $MRK Stake Decreased by Cullen Capital Management LLC - MarketBeat
Number of shareholders of Merck & Co., Inc. – MIL:1MRKX - TradingView
33,787 Shares in Merck & Co., Inc. $MRK Purchased by Gator Capital Management LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Circle Wealth Management LLC - MarketBeat
Atalanta Sosnoff Capital LLC Takes $13.36 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Traders Buy High Volume of Merck & Co., Inc. Call Options (NYSE:MRK) - MarketBeat
Merck & Co. Inc. stock underperforms Friday when compared to competitors - MarketWatch
Merck's Belzutifan Combination Approved by FDA for Adjuvant Treatment of Renal Cell Carcinoma - Moomoo
Merck wins FDA label expansion for Welireg in kidney cancer - Seeking Alpha
MRK Purchasers Have Opportunity to Lead Merck & Co., Inc. Securi - GuruFocus
Wescott Financial Advisory Group LLC Sells 13,382 Shares of Merck & Co., Inc. $MRK - MarketBeat
ICICI Prudential Asset Management Co Ltd Sells 43,800 Shares of Merck & Co., Inc. $MRK - MarketBeat
INVESCO V.I. Health Care Fund's Merck & Co Inc(MRK) Holding History - GuruFocus
Nuveen LLC Has $732.41 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck Animal Health announces acquisition of TARGAN - ROI-NJ
Finanzdaten der Merck Co Inc-Aktie (MRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):